Literature DB >> 1336421

Functional characterization of human IL-10.

H Spits1, R de Waal Malefyt.   

Abstract

Rapid progress has been made over the past two years in the characterization of the biological activities of interleukin-10. Interleukin-10, produced by T cells, B cells, macrophages/monocytes and keratinocytes, alters profoundly the morphology, the expression of MHC class II antigens and the production of cytokines by monocytes which in turn can affect a variety of immunological responses including antigen specific proliferation and cytokine production of both soluble and allo-antigens by T cells, cytokine production by natural killer cells and immunoglobulin production by B cells. IL-10 also directly affects the function and growth of T cells, B cells and mast cells. These characteristics indicate that IL-10 has strong anti-inflammatory activities and may act as a general suppressor factor of immune reactions with consequences for transplantation, tolerance, cancer therapy and infectious diseases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1336421     DOI: 10.1159/000236329

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  48 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  Dose-dependent changes in influenza virus-infected dendritic cells result in increased allogeneic T-cell proliferation at low, but not high, doses of virus.

Authors:  SangKon Oh; J Michael McCaffery; Maryna C Eichelberger
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Lister strain vaccinia virus with thymidine kinase gene deletion is a tractable platform for development of a new generation of oncolytic virus.

Authors:  J Hughes; P Wang; G Alusi; H Shi; Y Chu; J Wang; V Bhakta; I McNeish; A McCart; N R Lemoine; Y Wang
Journal:  Gene Ther       Date:  2015-04-16       Impact factor: 5.250

4.  Association of promoter region single nucleotide polymorphisms at positions -819C/T and -592C/A of interleukin 10 gene with ischemic heart disease.

Authors:  Gyeong-Im Yu; Ho-Chan Cho; Yun-Kyeong Cho; Hyoung-Seob Park; Hyuck-Jun Yoon; Hyung-Seop Kim; Chang-Wook Nam; Yoon-Nyun Kim; Kwon-Bae Kim; Eunyoung Ha; Dong-Hoon Shin; Seung-Ho Hur
Journal:  Inflamm Res       Date:  2012-05-17       Impact factor: 4.575

5.  Detection of T cells secreting type 1 and type 2 cytokines in the peripheral blood of patients with oral lichen planus.

Authors:  F Kalogerakou; E Albanidou-Farmaki; A K Markopoulos; D Z Antoniades
Journal:  Hippokratia       Date:  2008       Impact factor: 0.471

6.  A sentinel function for teat tissues in dairy cows: dominant innate immune response elements define early response to E. coli mastitis.

Authors:  Manuela Rinaldi; Robert W Li; Douglas D Bannerman; Kristy M Daniels; Christina Evock-Clover; Marcos V B Silva; Max J Paape; Bernadette Van Ryssen; Christian Burvenich; Anthony V Capuco
Journal:  Funct Integr Genomics       Date:  2009-08-29       Impact factor: 3.410

7.  Epstein-Barr virus recombinants with specifically mutated BCRF1 genes.

Authors:  S Swaminathan; R Hesselton; J Sullivan; E Kieff
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

Review 8.  Interleukin-10 and chronic liver disease.

Authors:  Li-Juan Zhang; Xiao-Zhong Wang
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

Review 9.  Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.

Authors:  Ankit Saxena; Sam Khosraviani; Sanjeev Noel; Divya Mohan; Thomas Donner; Abdel Rahim A Hamad
Journal:  Cytokine       Date:  2014-12-04       Impact factor: 3.861

10.  IL-10 -1082 G>A: a risk for prostate cancer but may be protective against progression of prostate cancer in North Indian cohort.

Authors:  Pravin Kesarwani; Dinesh Kumar Ahirwar; Anil Mandhani; Anand Narayan Singh; Divakar Dalela; Anand Narain Srivastava; Rama D Mittal
Journal:  World J Urol       Date:  2009-01-15       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.